The 2013 China 20 Top firms in II’s China 20 reap big asset gains as regulators allow a proliferation of new product offerings. September 30, 2013 Related Articles Premium Hedge Funds Capture Big Early Gains in Select Biotech IPOs — With One Notable Exception Stephen Taub Amrita Tiwari, New York Life Investment Management Institutional Investor If Your Nonprofit Feels Stretched Thin, an OCIO Can Help Sponsored by Fidelity Investments